Companies / Sarepta Therapeutics, Inc. / Activity
Activity — Sarepta Therapeutics, Inc.
37 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Behrens M Kathleen Director | Other | Common Stock | $144.0K | -6K -3.18% | 197,482 0.19% of shares | low |
| Jan 29, 2026 | Nicaise Claude Director | Exercise | Common Stock | $144.0K | +11K +37.75% | 38,312 0.04% of shares | low |
| Jan 27, 2026 | Behrens M Kathleen Director | Exercise | Common Stock | $144.0K | +11K +5.43% | 203,976 0.19% of shares | low |
| Jan 29, 2026 | Nicaise Claude Director | Other | Common Stock | $143.9K | -7K -17.70% | 31,532 0.03% of shares | low |
| Mar 12, 2026 | Mayo Stephen Director | Sell | Common Stock | $123.2K | -7K -80.40% | 1,765 <0.01% of shares | medium |
| Feb 26, 2026 | Estepan Ian Michael Executive | Exercise | Common Stock | $73.8K | +5K +2.75% | 200,750 0.19% of shares | low |
| Mar 2, 2026 | Rodino-Klapac Louise Executive | Other | Common Stock | $60.2K | -4K -1.60% | 228,437 0.22% of shares | low |
| Mar 2, 2026 | Estepan Ian Michael Executive | Other | Common Stock | $53.5K | -3K -1.58% | 205,574 0.19% of shares | low |
| Feb 26, 2026 | Estepan Ian Michael Executive | Exercise | Common Stock | $28.4K | +2K +1.07% | 195,369 0.18% of shares | low |
| Mar 11, 2026 | Estepan Ian Michael Executive | Other | Common Stock | $18.7K | -1K -0.54% | 201,983 0.19% of shares | low |
| Mar 9, 2026 | Estepan Ian Michael Executive | Other | Common Stock | $17.6K | -1K -0.51% | 203,663 0.19% of shares | low |
| Mar 11, 2026 | Rothfuss Cristin Executive | Other | Common Stock | $16.6K | -974 -0.70% | 137,544 0.13% of shares | low |
| Mar 11, 2026 | Rodino-Klapac Louise Executive | Other | Common Stock | $16.1K | -948 -0.42% | 225,323 0.21% of shares | low |
| Mar 9, 2026 | Rodino-Klapac Louise Executive | Other | Common Stock | $15.2K | -895 -0.39% | 226,271 0.21% of shares | low |
| Mar 2, 2026 | Estepan Ian Michael Executive | Other | Common Stock | $14.2K | -875 -0.43% | 204,699 0.19% of shares | low |
| Mar 2, 2026 | Rodino-Klapac Louise Executive | Other | Common Stock | $12.4K | -767 -0.34% | 227,670 0.22% of shares | low |
| Mar 9, 2026 | Estepan Ian Michael Executive | Other | Common Stock | $9.9K | -583 -0.29% | 203,080 0.19% of shares | low |
| Mar 9, 2026 | Rodino-Klapac Louise Executive | Other | Common Stock | $8.5K | -504 -0.22% | 227,166 0.22% of shares | low |
| Mar 9, 2026 | Rothfuss Cristin Executive | Other | Common Stock | $8.2K | -484 -0.35% | 138,864 0.13% of shares | low |
| Mar 2, 2026 | Wong Ryan Ho-Yan Executive | Other | Common Stock | $7.3K | -450 -0.33% | 135,595 0.13% of shares | low |
| Mar 2, 2026 | Rothfuss Cristin Executive | Other | Common Stock | $6.6K | -408 -0.29% | 139,348 0.13% of shares | low |
| Mar 9, 2026 | Rothfuss Cristin Executive | Other | Common Stock | $5.9K | -346 -0.25% | 138,518 0.13% of shares | low |
| Mar 11, 2026 | Wong Ryan Ho-Yan Executive | Other | Common Stock | $4.4K | -256 -0.19% | 135,064 0.13% of shares | low |
| Mar 9, 2026 | Wong Ryan Ho-Yan Executive | Other | Common Stock | $2.7K | -162 -0.12% | 135,433 0.13% of shares | low |
| Mar 9, 2026 | Wong Ryan Ho-Yan Executive | Other | Common Stock | $1.9K | -113 -0.08% | 135,320 0.13% of shares | low |
| Jun 4, 2026 | Connelly Deirdre P Director | Grant | Common Stock | — | +17K +322.97% | 22,100 0.02% of shares | low |
| Jun 4, 2026 | Behrens M Kathleen Director | Grant | Common Stock | — | +17K +8.55% | 214,357 0.20% of shares | low |
| Mar 1, 2026 | Estepan Ian Michael Executive | Exercise | Performance Stock Units | — | -8K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Estepan Ian Michael Executive | Exercise | Common Stock | — | +8K +4.05% | 208,875 0.20% of shares | low |
| Feb 26, 2026 | Estepan Ian Michael Executive | Exercise | Stock Option (right to buy) | — | -5K -100.00% | 0 0.00% of shares | low |
| Feb 26, 2026 | Estepan Ian Michael Executive | Exercise | Stock Option (right to buy) | — | -2K -100.00% | 0 0.00% of shares | low |
| Feb 25, 2026 | Estepan Ian Michael Executive | Grant | Performance Stock Units | — | +2K +30.00% | 8,125 <0.01% of shares | low |
| Mar 1, 2026 | Rodino-Klapac Louise Executive | Exercise | Performance Stock Units | — | -8K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Rodino-Klapac Louise Executive | Exercise | Common Stock | — | +8K +3.63% | 232,155 0.22% of shares | low |
| Feb 25, 2026 | Rodino-Klapac Louise Executive | Grant | Performance Stock Units | — | +2K +30.00% | 8,125 <0.01% of shares | low |
| Jan 29, 2026 | Nicaise Claude Director | Exercise | Stock Option (right to buy) | — | -11K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Behrens M Kathleen Director | Exercise | Stock Option (right to buy) | — | +11K | 0 0.00% of shares | low |